chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Jan2021 as dose 1, single (Lot number: EL3248), in left arm, on 03Feb2021 as dose 2, single (Lot number: EL3247), in left arm and on 13Oct2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 45 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results; Positive, notes: I had a serious rebound of COVID Required ER visit for vomiting, diarrhea, nausea, consistent fever of 102-103 for 4 days. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Other medication in 2 weeks was reported as yes.
Patient received 1st dose and got some adverse side effects, called 911; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Patient received 1st dose and got some adverse side effects, called 911) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION COMPLICATION (Patient received 1st dose and got some adverse side effects, called 911). At the time of the report, VACCINATION COMPLICATION (Patient received 1st dose and got some adverse side effects, called 911) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information were not provided.
5 min after receiving vaccine the site was hard, ice was immediately applied. Then site ((L) delt) became itchy & pt had itchy throat. Sent to ED, received IV BENADRYL & IV ZANTAC. Went home with one week course of PO BENADRYL & ZANTAC.
Pt recvd vax 22JUN92 around 1030AM & went into convuls; pt rushed to hosp stopped breathing while being checked in;
headache,  fluey,  shaking and felt cold, deep muscle ache. Pt still has aching ,headache ,and sore arm.
I developed a Severe rash (blotchy, red, itchy ) all over both arms and back 36 hours post 2nd dose Pfizer vaccine. I had a high fever of 103 and massive headache too and body aches
Both arms feel a little hot; Electrolyte imbalance; Carpal tunnel syndrome; The pain on her lower arms would still occur once in a while and she says that they feel a little hot.; Tingling on her fingers - the right pinky, 4th and maybe even the 3rd; Weird numbness on her fingers; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on her fingers - the right pinky, 4th and maybe even the 3rd), HYPOAESTHESIA (Weird numbness on her fingers), FEELING HOT (Both arms feel a little hot), ELECTROLYTE IMBALANCE (Electrolyte imbalance) and PAIN IN EXTREMITY (The pain on her lower arms would still occur once in a while and she says that they feel a little hot.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Jun-2021, the patient experienced PARAESTHESIA (Tingling on her fingers - the right pinky, 4th and maybe even the 3rd), HYPOAESTHESIA (Weird numbness on her fingers) and PAIN IN EXTREMITY (The pain on her lower arms would still occur once in a while and she says that they feel a little hot.). On an unknown date, the patient experienced FEELING HOT (Both arms feel a little hot), ELECTROLYTE IMBALANCE (Electrolyte imbalance) and CARPAL TUNNEL SYNDROME (Carpal tunnel syndrome). At the time of the report, PARAESTHESIA (Tingling on her fingers - the right pinky, 4th and maybe even the 3rd), HYPOAESTHESIA (Weird numbness on her fingers), FEELING HOT (Both arms feel a little hot), ELECTROLYTE IMBALANCE (Electrolyte imbalance) and PAIN IN EXTREMITY (The pain on her lower arms would still occur once in a while and she says that they feel a little hot.) had not resolved and CARPAL TUNNEL SYNDROME (Carpal tunnel syndrome) outcome was unknown.            No concomitant medications information was not reported No treatment medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 27-Sep-2021: Significant follow-up, gender of patient and event was added.
Information has been received from a physician concerning a female who on 04-DEC-2007 was vaccinated with Gardasil. The nurse administering the vaccine had blood mix in the syringe after aspirating. The nurse discarded the syringe with the Gardasil and blood mixture. The patient did not receive any product from this syringe. The office gave the patient another Gardasil (new vial and syringe) that was free of blood at another site. On 04-DEC-2007 the patient experienced pain because it required 2 skin penetrations to get 1 Gardasil dose. Neither dose was a prefilled syringe. The patient sought medical attention in the office and her outcome was not reported. Additional information has been requested.
abdominal pain; Cramps; Vomiting; sore arm; Initial information was received on 21-Oct-2021 regarding an unsolicited valid non-serious case from pharmacist via a non-healthcare professional via call center via Global Medical Information (GMI) (Reference number- 00822956) in the United States.  This case is linked to cases 2021SA355291, 2021SA357413 and 2021SA359230 (same reporter).  This case involves a patient of (unknown demographics) who had abdominal pain, cramps (muscle spasms), vomiting and sore arm (pain in extremity) when received vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a 0.7 ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (injection, total, once, lot number: UJ732AB and expiry date: 30-JUN-2022) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious abdominal pain, cramps (muscle spasms), vomiting and sore arm (pain in extremity) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  It was reported "The caller wants to know if their office had received a bad batch of the vaccine. She said that she gave all the vaccinations and about 10 percent of about 70 patients had injection site reactions to varying degrees, a lot more than they usually have. There were times when she could see the reactions happening right after the injection. She does not know the exact number of patients. They all received the same lot. Then she said, 2 patient had severe reactions. One had abdominal pain, cramps, vomiting and a sore arm. The other patient had those symptoms and also fever, chills and headache."  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment for the events.  At the time of reporting, the outcome was unknown for the events (abdominal pain, muscle spasms, vomiting and pain in extremity).  The reporter assessed the causal relationship for events (abdominal pain, muscle spasms, vomiting and pain in extremity) with the FLUZONE HIGH-DOSE QUADRIVALENT as not reported.
Right forearm cellulitis, two vesicular eruptions. Rash occurred 10 days after receiving smallpox vaccine on same arm.
On the armpit has a blister like with some fluid underneath it; On the armpit has a blister like with some fluid underneath it and is painful; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (On the armpit has a blister like with some fluid underneath it) and AXILLARY PAIN (On the armpit has a blister like with some fluid underneath it and is painful) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Aug-2021, the patient experienced BLISTER (On the armpit has a blister like with some fluid underneath it) and AXILLARY PAIN (On the armpit has a blister like with some fluid underneath it and is painful). At the time of the report, BLISTER (On the armpit has a blister like with some fluid underneath it) and AXILLARY PAIN (On the armpit has a blister like with some fluid underneath it and is painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medication and treatment medication was reported.  Patient reported that the patient was missing an opportunity of a lifetime due to this side effect.
One week post vaccine pt complained of fatigue and aches.  On 02/07/04, onset of raised, blistering skin eruptions on the face, scalp, chest, back.
after she took the 2nd dose, she felt nauseous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 22Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), administration date: 01Apr2021, for COVID-19 immunisation. The following information was reported: NAUSEA (non-serious) with onset Apr2021, outcome "unknown", described as "after she took the 2nd dose, she felt nauseous".  Additional Information: The patient was asking if she can take an anti-nausea pill.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Tested positive for covid on 1Feb2021; Tested positive for covid on 1Feb2021; This is a spontaneous report from a contactable consumer (Reporter's husband). An unspecified age 70-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, via an unspecified route of administration on 21Jan2021 at single dose for covid-19 immunisation. Patient's medical history was not reported. The patient's concomitant medications were not reported. The patient reported Caller, female, calling about her husband, aged 70, who received first dose on 21Jan2021. He developed symptoms on 30Jan2021 and tested positive for covid on 01Feb2021. Her husband is due to get vaccine on 11Feb2021. Can he still receive it?. The outcome of the events was "Unknown".  Information about Batch/Lot number has been requested.
i have a large lump underneath my skin where the vaccine was given and its not going away. sometimes lump is hard sometimes lump is soft
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history, concomitant medications, drug reactions or allergies were not reported. On unknown dates between 06-MAR-2017 and 10-APR-2017, the multiple unspecified patients were vaccinated with improperly stored doses (also reported as doses were administered before temperature excursion) of ZOSTAVAX injection (lot# M036297, expiry date 14-NOV-2017, dose, route of administration). Sterile diluent used to reconstituted vaccines was properly stored. No adverse effects were reported. No product quality complain was involved. The vaccines were stored in the temperature between 6 and 14 degrees Fahrenheit for 1 hour. There was no previous temperature excursion. Digital data logger was involved.  This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1704USA005927: US-009507513-1705USA000160:
Patient is fully vaccinated.  COVID + at ED visit on 1/5/2022.  49-year-old male with a history of HIV presents to the emergency department complaining of fever, nausea, vomiting. Symptoms present for the last 3 days. Denies any chest pain or shortness of breath. He does have a dry cough. Having some runny nose and sore throat. BP 108/58  | Pulse 114  | Temp 100.3 °F (37.9 °C) (Oral)  | Resp 22  | Ht 190.5 cm (6' 3")  | Wt 88.5 kg (195 lb)  | SpO2 93%  | BMI 24.37 kg/m² CXR: Minor blunting of the right sulcus. There may be slight atelectasis at right base as well.Vital signs were reviewed and the patient was noted to be tachycardic. He was given IV fluids, Zofran, Toradol, Tylenol.Potassium low at 3.0, this was repleted. Creatinine is 1.3. Discharged from ED.
Headache; Greater then 35 days between Covid-19 vaccinations; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater then 35 days between Covid-19 vaccinations) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, the patient experienced HEADACHE (Headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater then 35 days between Covid-19 vaccinations). On 24-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater then 35 days between Covid-19 vaccinations) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown.            No concomitant medications were reported No treatment information was reported.   This case was linked to MOD-2021-081668 (Patient Link).
The pt and her sibling both have onset of rash with individual red macules, suggestive of early varicella. They are not vesicular at this time. Both were exposed on 12/24/01 to a relative who broke out on 12/25/01 with classic chickenpox.
She got COVID; She got COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Nov2022 as dose 6 (booster), single (Lot number: GJ3275) at the age of 70 years, in arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 25Feb2021 as dose 1, single (Lot number: EN5318), in arm, on 25Mar2021 as dose 2, single (Lot number: EN6199), in arm, on 03Sep2021 as dose 3 (booster), single (Lot number: FC3182), in arm, on 17Mar2022 as dose 4 (booster), single (Lot number: FK9895), in arm and on 17Aug2022 as dose 5 (booster), single (Lot number: FP7150), in arm for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis", start date: 1983 (unspecified if ongoing); "immunocompromised" (unspecified if ongoing); "heart patient" (unspecified if ongoing); "cough" (unspecified if ongoing); "got three replacement joints" (unspecified if ongoing); "surgery" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 11Apr2023, outcome "unknown" and all described as "She got COVID". The patient underwent the following laboratory tests and procedures: Body height: (unspecified date) 4ft 11in, notes: Lost a couple of inches stating 4ft 11in is probably correct; Body temperature: (unspecified date) 100, notes: she got a low grade fever of 100-100.1; (unspecified date) 100.1, notes: she got a low grade fever of 100-100.1; SARS-CoV-2 test: (unspecified date) Negative, notes: Tested negative after a couple days; (11Apr2023) Positive, notes: She was positive for COVID again on 11Apr2023. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Symptoms started evening of 10Apr2023. First day she could go out with the mask on was 10Apr2023 and she felt a little bit of symptoms that night. She was positive for COVID again on 11Apr2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300157613 Same product and event, different patient;
Within 3 hours after receiving the flu vaccine I had pain in upper shoulder with decreased movement and inability to raise my arm. The symptoms worsened and two days later (on 10/22) I was unable to lift my arm. I was treated at local emergency department for traumatic bursitis.
Improperly stored doses; This spontaneous report has been received from an other health care professional referring to a 10 year old female patient. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.     On an unknown date, the patient was vaccinated with improperly stored vaccines measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II),  by intramuscular route, (strength, frequency, dose, anatomical location, and expiration date were not provided) for prophylaxis and hepatitis b virus vaccine (unspecified)(HEPATITIS B VIRUS VACCINE (UNSPECIFIED)) by intramuscular route (strength, frequency, dose, anatomical location, and expiration date were not provided).  Lot number S012472 is an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II).
TRANSIENT CEREBRAL ISCHEMIA ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY ACUTE HYPOXEMIC RESPIRATORY FAILURE
Patient presented on 11/5/10 with symptoms of anxiety and depression. Worsened overnight and was hospitalized for psychosis on 11/7/10.
Starting the day after the shot, the arthritis in my hip flared up severely. I had a lot of trouble walking. I saw my doctor who prescribed Physical therapy. I started doing physical therapy to help my mobility. I had to start using a cane and still am to this day.
was inadvertently given dose 2 of Shingrix subcutaneously; swollen arm; red arm; This case was reported by a pharmacist via call center representative and described the occurrence of swelling arm in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number 7AN44, expiry date 30th April 2021) for prophylaxis.   On 16th December 2019, the patient received the 2nd dose of Shingrix (subcutaneous) .5 ml. In December 2019, less than a week after receiving Shingrix, the patient experienced swelling arm and erythema of extremities. On 16th December 2019, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the swelling arm, erythema of extremities and intramuscular formulation administered by other route were unknown.   It was unknown if the reporter considered the swelling arm and erythema of extremities to be related to Shingrix.  Additional details were provided as follows: The patient experienced red swollen arm  around the injection site. The patient inadvertently received Shingrix subcutaneously instead of intramuscularly, which led to formulation administered by other route. The reporter did not consent to follow-up. The reporter declined for the follow-up.
Patient reported left arm numbness. Went to the hospital for full stroke evaluation all tests returned negative. (CT scan, MRI, etc.). Patient was observed overnight and released from hospital with resolved symptoms and negative report of any stroke or mini-stroke. Patient has had follow-up appointments with PCP and Cardiologist. Received ok from PCP prior to second dose vaccination of COVID.
fever 102 day 8;fine rash day 9;inc rash (abd, arms, neck, face) day 12;no fever;
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    No concomitant medication was provided by reporter. No treatment medication was provided by reporter.
I broke out in shingles in early June 2021. I was kind of weird,  noticed my lower neck was kind of swollen, bit of a rash and so I told my sister. It was very itchy.  I went to urgent care and followed up with PCP, called my doctor. My PCP had sent in a prescription for Valtrex medication.  I have no symptoms today.
fever to 103 8APR94; febrile seizure 9APR94 & 10APR94-t105; concurrent otitis media/started 1NOV94; still present @ ER visit 9APR93;
Was seen in office on 8/30/18 with well-circumscribed, erythematous, edematous wheals over the buttocks and bilateral lower extremities noted. Patient did have fever on 8/29/18, but resolved before appointment on 8/30/18. On 8/21/18, patient received 12 month vaccines and ROCEPHIN.  This was followed by a prescription of OMNICEF for 10 days.